Hoyle Cohen, LLC Amarin Corp Plcuk Transaction History

Hoyle Cohen, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$3.94 - $5.84 $19,700 - $29,200	-5,000 Reduced 33.33%	10,000 $51,000
Q1 2021 May 14, 2021	SELL	$5.03 - $8.8 $55,330 - $96,800	-11,000 Reduced 42.31%	15,000 $93,000
Q4 2020 Feb 12, 2021	BUY	$4.04 - $5.31 $105,040 - $138,060	26,000 New	26,000 $127,000
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $271,779 - $503,262	-21,900 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$2.45 - $16.27 $12,005 - $79,723	4,900 Added 28.82%	21,900 $356,000
Q2 2018 Aug 06, 2018	SELL	$2.68 - $3.48 $31,892 - $41,412	-11,900 Reduced 41.18%	17,000 $53,000
Q1 2018 May 15, 2018	SELL	$2.99 - $4.44 $19,734 - $29,304	-6,600 Reduced 18.59%	28,900 $87,000
Q4 2017 Feb 15, 2018	BUY	$3.06 - $4.09 $108,630 - $145,195	35,500	35,500 $142,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

Stay updated on Hoyle Cohen, LLC with notifications on news.